Xeruborbactam

N/A

Report date: 2025/09/23 15:09:16
NME

Base Information

Drug NameXeruborbactam
Drug Alias Nameultra broad spectrum intavenous beta-lactamase inhibitorsultra broad spectrum oral beta-lactamase inhibitorsOMNIvanceQPX-7728BRII-636
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQpex Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesShionogi IncQpex Biopharma IncBiomedical Advanced Research And Development Authority +[4] 
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A